Bromhexine-Darnitsa tablets 8 mg No. 50

Bromhexine Darnitsa is a medicine used for coughs and colds. For secretolytic therapy in acute and chronic bronchopulmonary diseases accompanied by complications of sputum discharge.

Warehouse

Contraindication

Hypersensitivity to the components of the drug; gastric and duodenal ulcers; diseases of the respiratory system, the course of which is accompanied by the formation of a large amount of liquid sputum.

Method of application

The drug should be taken orally, regardless of meals. The duration of administration depends on the indications and course of the disease and is determined individually.

Adults and children over 14 years of age: 1-2 tablets (8-16 mg) 3 times a day. The course of treatment is 4-5 days.

Children aged 6 to 14 years, as well as patients weighing less than 50 kg: 1 tablet (4-8 mg) 3 times a day. The course of treatment is 4-5 days.

Application features

Use the drug with caution in patients suffering from bronchial asthma and in patients with renal or severe hepatic insufficiency (i.e. increase the intervals between doses or reduce the dose).

In acute renal failure, the possibility of accumulation of bromhexine metabolites in the liver must be taken into account.

Pregnant women

During pregnancy, the drug is prescribed taking into account the benefit to the mother/risk to the fetus ratio.

Children

The medicine should be used in children over 6 years of age. Children under 6 years of age should be used in other dosage forms.

Drivers

There are no reports that the drug may affect the ability to drive or operate other mechanisms.

Overdose

Dyspeptic disorders, nausea, vomiting, diarrhea, dizziness, headache, diplopia, ataxia, mild metabolic acidosis, tachypnea. No chronic toxic effects on humans have been identified.

Side effects

From the nervous system: headache (migraine type), dizziness.

On the part of the respiratory system, thoracic organs and mediastinum: increased cough, bronchospasm, respiratory disorders, respiratory distress.

Gastrointestinal: dyspeptic symptoms, nausea, vomiting, diarrhea, abdominal pain, exacerbation of gastric and duodenal ulcers, transient increase in serum aminotransferase activity.

Storage conditions

Store in original packaging at a temperature not exceeding 25°C. Keep out of the reach of children.